Respira® is a preparation of Levosulbutamol sulphate. It is a beta 2 agonist and indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 4 years of age and older with reversible obstructive airway disease.
- Same efficacy compared to salbutamol but with least systemic load
- Assures less systemic load
- Offers less side effects & reduced ß-mediated adverse effects
- High safety & tolerability than the racemate
- Improves lung function.